Phospho-IKB alpha (S32) Recombinant Rabbit Monoclonal Antibody [ST53-05]
Usd: 385 Special Discount
Specification
Safety datasheet
Overview
Product Name
Phospho-IKB alpha (S32) Recombinant Rabbit Monoclonal Antibody [ST53-05]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic phospho-peptide corresponding to residues surrounding Ser32 of human IKB alpha.
Species Reactivity
Human, Mouse
Validated Applications
WB, IF-Cell, IP
Molecular Weight
Predicted band size: 36 kDa
Positive Control
HeLa treated with 20ng/mL TNF-α for 5 minutes cell lysate, HeLa treated with 100nM Calyculin A for 30 minutes cell lysate, RAW264.7 treated with 50ng/mL Calyculin A for 45 minutes cell lysate, NIH/3T3 cells were starved for 18 hours then treated with 20 ng/ml TNF alpha for 5 minutes, HeLa.
Conjugation
unconjugated
Clone Number
ST53-05
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:1,000-1:5,000
-
IF-Cell
-
1:50-1:200
-
IP
-
Use at an assay dependent concentration.
Target
Function
On the basis of both functional and structural considerations, members of the IκB family of proteins can be divided into four groups. The first of these groups, IκB-α, includes the avian protein pp40 and the mammalian MAD-3, both of which inhibit binding of p50-p65 NFkB complex or Rel protein to their cognate binding sites but do not inhibit the binding of p50 homodimer to κB sites, suggesting that the IκB-α family binds to the p65 subunit of p50-p65 heterocomplex through ankyrin repeats. The second member of the IκB family is represented by a protein designated IκB-β. The third group of IκB proteins is represented by IκB-γ, which is identical in sequence with the C-terminal domain of the p110 precursor of NFkB p50 and is expressed predominantly in lymphoid cells. An additional IκB family member, IκB-ε, has several phosphorylated forms and is primarily found complexed with Rel A and/or c-Rel.
Background References
1. Liu Y et al. The natural compound magnolol inhibits invasion and exhibits potential in human breast cancer therapy. Sci Rep 3:3098 (2013).
2. Kiefel H et al. EMT-associated up-regulation of L1CAM provides insights into L1CAM-mediated integrin signalling and NF- B activation. Carcinogenesis 33:1919-29 (2012).
Sequence Similarity
Belongs to the NF-kappa-B inhibitor family.
Post-translational Modification
Phosphorylated; disables inhibition of NF-kappa-B DNA-binding activity. Phosphorylation at positions 32 and 36 is prerequisite to recognition by UBE2D3 leading to polyubiquitination and subsequent degradation.; Sumoylated; sumoylation requires the presence of the nuclear import signal. Sumoylation blocks ubiquitination and proteasome-mediated degradation of the protein thereby increasing the protein stability.; Monoubiquitinated at Lys-21 and/or Lys-22 by UBE2D3. Ubiquitin chain elongation is then performed by CDC34 in cooperation with the SCF(FBXW11) E3 ligase complex, building ubiquitin chains from the UBE2D3-primed NFKBIA-linked ubiquitin. The resulting polyubiquitination leads to protein degradation. Also ubiquitinated by SCF(BTRC) following stimulus-dependent phosphorylation at Ser-32 and Ser-36.; Deubiquitinated by porcine reproductive and respiratory syndrome virus Nsp2 protein, which thereby interferes with NFKBIA degradation and impairs subsequent NF-kappa-B activation.
Subcellular Location
Cytoplasm, Nucleus.
Synonyms
I kappa B alpha antibody
I-kappa-B-alpha antibody
IkappaBalpha antibody
IkB-alpha antibody
IKBA antibody
IKBA_HUMAN antibody
IKBalpha antibody
MAD 3 antibody
MAD3 antibody
Major histocompatibility complex enhancer-binding protein MAD3 antibody
ExpandI kappa B alpha antibody
I-kappa-B-alpha antibody
IkappaBalpha antibody
IkB-alpha antibody
IKBA antibody
IKBA_HUMAN antibody
IKBalpha antibody
MAD 3 antibody
MAD3 antibody
Major histocompatibility complex enhancer-binding protein MAD3 antibody
NF kappa B inhibitor alpha antibody
NF-kappa-B inhibitor alpha antibody
NFKBI antibody
NFKBIA antibody
Nuclear factor of kappa light chain gene enhancer in B cells antibody
Nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor alpha antibody
CollapseImages
-
☑ Cell treatment (CT)
Western blot analysis of Phospho-IKB alpha (S32) on different lysates with Rabbit anti-Phospho-IKB alpha (S32) antibody (ET1609-78) at 1/1,000 dilution.
Lane 1: HeLa cell lysate
Lane 2: HeLa treated with 20ng/mL TNF-α for 5 minutes cell lysate
Lane 3: HeLa treated with 20ng/mL TNF-α for 5 minutes cell lysate, then the membrane treated with λpp for 1 hour
Lysates/proteins at 20 µg/Lane.
Predicted band size: 36 kDa
Observed band size: 36 kDa
Exposure time: 1 minute 2 seconds;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1609-78) at 1/1,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
☑ Cell treatment (CT)
Western blot analysis of Phospho-IKB alpha (S32) on different lysates with Rabbit anti-Phospho-IKB alpha (S32) antibody (ET1609-78) at 1/5,000 dilution.
Lane 1: HeLa cell lysate (20 µg/Lane)
Lane 2: HeLa treated with 100nM Calyculin A for 30 minutes cell lysate (20 µg/Lane)
Lane 3: RAW264.7 cell lysate (20 µg/Lane)
Lane 4: RAW264.7 treated with 50ng/mL Calyculin A for 45 minutes cell lysate (20 µg/Lane)
Predicted band size: 36 kDa
Observed band size: 36 kDa
Exposure time: 59 seconds; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1609-78) at 1/5,000 dilution was used in primary antibody dilution (K1803) at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
☑ Cell treatment (CT)
Western blot analysis of Phospho-IKB alpha (S32) on NIH-3T3 cell lysates.
Lane 1: NIH/3T3 cells were starved for 18 hours, whole cell lysate, 10 ug/lane.
Lane 2: NIH/3T3 cells were starved for 18 hours, then treated with 20 ng/ml TNF alpha for 5 minutes, whole cell lysates, 10 ug/lane.
Lane 3: NIH/3T3 cells were starved for 18 hours, then treated with 20 ng/ml TNF alpha for 10 minutes, whole cell lysates, 10 ug/lane.
Proteins were transferred to a PVDF membrane and blocked with 5% BSA in PBS for 1 hour at room temperature. The primary antibody Anti-Phospho-IKB alpha (S32) (ET1609-78, 1/1,000) , Anti-IKB alpha antibody ( ET1603-6, 1/2,000) and Anti-GAPDH antibody (ET1601-4, 1/10,000)was used in 5% BSA at room temperature for 2 hours. Goat Anti-Rabbit IgG H&L (HRP) Secondary Antibody (HA1001) at 1:200,000 dilution was used for 1 hour at room temperature.
Predicted band size: 36 kDa
Observed band size: 36 kDa
Exposure time: 1 minute -
Immunocytochemistry analysis of HeLa cells labeling Phospho-IKB alpha (S32) with Rabbit anti-Phospho-IKB alpha (S32) antibody (ET1609-78) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-Phospho-IKB alpha (S32) antibody (ET1609-78) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution.
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Baimaside, a flavonoid glycoside from Apocynum venetum, ameliorates sepsis by allosterically inhibiting NF-κB p50-mediated IL-6 transcription
Journal: Biochemical Pharmacology
DOI: 10.1016/j.bcp.2026.117868
IF: 5.6
Application: WB
Reactivity: Mouse
Publish date: 2026 Mar
-
New co-drugs of O-demethylvenlafaxine and NSAIDs exert antidepressant effects by alleviating inflammation, oxidative stress, and increasing neurotransmitter
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2026.116456
IF: 4.7
Application: WB
Reactivity: Mouse
Publish date: 2026 Mar
-
Capilliposide from Lysimachia capillipes Hemsl. shows anti-inflammatory and anti-pyretic effects via the MAPK/iNOS/NF-κB pathway
Journal: Journal of Pharmacy and Pharmacology
DOI: 10.1093/jpp/rgag021
IF: 3.2
Application: WB
Reactivity: Mouse
Publish date: 2026 Mar
-
Sequential Macrophage Polarization Mediated by a Biphasic Cold Plasma Pen for Oral Ulcer Therapy
Journal: ACS Applied Materials & Interfaces
DOI: 10.1021/acsami.5c25563
IF: 8.2
Application: WB
Reactivity: Mouse
Publish date: 2026 Mar
-
Gut Metabolite Indoleacrylic Acid Suppresses Osteoclast Formation by AHR mediated NF-κB Signaling Pathway
Journal: International Journal Of Biological Sciences
DOI: 10.7150/ijbs.124766
IF: 10
Application: WB
Reactivity: Mouse
Publish date: 2026 Jan
-
Necroptosis mediated by FKBP5 in alveolar fibroblasts drives Pseudomonas aeruginosa-induced acute lung injury
Journal: International Immunopharmacology
DOI: 10.1016/j.intimp.2026.116368
IF: 4.7
Application: WB
Reactivity: Mouse,Human
Publish date: 2026 Feb
-
Collagen peptides derived from sea bass scales (Lateolabrax maculatus) relieve photoaging through MAPK, NF-κB and TGF-β signaling pathways and modulating gut microbiota composition
Journal: Food Research International
DOI: 10.1016/j.foodres.2025.117521
IF: 8
Application: WB
Reactivity: Mouse
Publish date: 2025 Sept
-
Tea seed-derived leucoside attenuates sepsis via inhibition of TLR4-MD2 complex formation
Journal: Biochemical Pharmacology
DOI: 10.1016/j.bcp.2025.117464
IF: 5.6
Application: WB
Reactivity: Mouse
Publish date: 2025 Oct
-
Therapeutic effects of Saussurea graminea Dunn and its active compounds in Sepsis-associated liver injury: Transcriptomics, metabolomics and experimental validation
Journal: Journal Of Ethnopharmacology
DOI: 10.1016/j.jep.2025.119985
IF: 4.8
Application: WB
Reactivity: Mouse
Publish date: 2025 May
-
Programmatically activated DNA hydrogel microcapsules for precision therapy in inflammatory bowel disease
Journal: Theranostics
DOI: 10.7150/thno.111583
IF: 12.4
Application: WB
Reactivity: Mouse
Publish date: 2025 May
-
FKBP5 Mediates Alveolar Fibroblast Necroptosis During Acute Respiratory Distress Syndrome
Journal: Cell Proliferation
DOI: 10.1111/cpr.70075
IF: 5.6
Application: WB
Reactivity: Mouse,Human
Publish date: 2025 Jun
-
Kv1.3 knockdown attenuates alcohol-related liver injury in mice through induction of tryptamine
Journal: Acta Pharmacologica Sinica
DOI: 10.1038/s41401-025-01544-4
IF: 8.4
Application: WB
Reactivity: Mouse
Publish date: 2025 Jun
-
SZC-6 Promotes Diabetic Wound Healing in Mice by Modulating the M1/M2 Macrophage Ratio and Inhibiting the MyD88/NF-χB Pathway
Journal: Pharmaceuticals
DOI: 10.3390/ph18081143
IF: 4.8
Application: WB
Reactivity: Mouse
Publish date: 2025 Jul
-
A Charge-Adhesive Targeted DNA Gel Bandage for the Precision Treatment of Inflammatory Bowel Disease
Journal: Advanced Science
DOI: 10.1002/advs.202509419
IF: 14.1
Application: WB
Reactivity: Mouse
Publish date: 2025 Jul
-
Ischemic Area-Targeting and Self-Monitoring Nanoprobes Ameliorate Myocardial Ischemia/Reperfusion Injury by Scavenging ROS and Counteracting Cardiac Inflammation
Journal: Advanced Science
DOI: 10.1002/advs.202414518
IF: 14.1
Application: WB
Reactivity: Mouse
Publish date: 2025 Jan
-
Danggui Beimu Kushen Pill Alleviates Colitis-Induced Inflammation in Mice by Regulating the IL-6/IL-6R and IL-17A/IL-17RA Signaling Pathways
Journal: Pharmaceuticals
DOI:
IF: 4.3
Application: WB
Reactivity: Mouse
Publish date: 2025 Jan
-
Danggui Beimu Kushen Pill Alleviates Colitis-Induced Inflammation in Mice by Regulating the IL-6/IL-6R and IL-17A/IL-17RA Signaling Pathways
Journal: Pharmaceuticals
DOI: 10.3390/ph18020141
IF: 4.8
Application: WB
Reactivity: Mouse
Publish date: 2025 Jan
-
Tgm2-Catalyzed Covalent Cross-Linking of IκBα Drives NF-κB Nuclear Translocation to Promote SASP in Senescent Microglia
Journal: Aging Cell
DOI:
IF: 8
Application: WB
Reactivity: Mouse
Publish date: 2025 Jan
-
Patchouli alcohol from Pogostemon cablin Benth inhibits H1N1 infection by repressing inflammasome and proptosis by targeting ubiquitin specific peptidase USP18
Journal: International Journal Of Biological Macromolecules
DOI: 10.1016/j.ijbiomac.2025.140670
IF: 7.7
Application: WB
Reactivity: Human
Publish date: 2025 Feb
-
Anti-Inflammatory Effect of 21α-Methylmelianol In Vitro and In Vivo via NF-κB/STAT Signaling Pathway Modulation
Journal: Food Science & Nutrition
DOI: 10.1002/fsn3.71310
IF: 3.8
Application: WB
Reactivity:
Publish date: 2025 Dec
-
Quyushengxin formula restores the integrity of intestinal barrier by regulating the gut microbiota to ameliorate DSS-induced ulcerative colitis in mice
Journal: Journal Of Ethnopharmacology
DOI: 10.1016/j.jep.2025.120992
IF: 5.4
Application: WB
Reactivity: Mouse
Publish date: 2025 Dec
-
Dectin-1 is Pathogenic in Chronic Kidney Disease by Promoting Macrophage Infiltration and Transition to Myofibroblast
Journal: International Journal Of Biological Sciences
DOI: 10.7150/ijbs.119129
IF: 10
Application: WB
Reactivity: Mouse
Publish date: 2025 Aug
-
Guaiane sesquiterpenoid—Glucozaluzanin C from Ainsliaea fragrans Champ. targeting binding to TLR4/p65 to regulate NF-κB/MAPK pathway alleviates sepsis-induced acute liver injury
Journal: Fitoterapia
DOI: 10.1016/j.fitote.2025.106579
IF: 2.5
Application: WB
Reactivity: Mouse
Publish date: 2025 Apr
-
Colostrum-derived extracellular vesicles: potential multifunctional nanomedicine for alleviating mastitis
Journal: Journal Of Nanobiotechnology
DOI:
IF: 10.6
Application: WB
Reactivity: Mouse
Publish date: 2024 Oct
-
Synbiotics containing sea buckthorn polysaccharides ameliorate DSS-induced colitis in mice via regulating Th17/Treg homeostasis through intestinal microbiota and their production of BA metabolites and SCFAs
Journal: International Journal Of Biological Macromolecules
DOI:
IF: 7.7
Application: WB
Reactivity: Mouse
Publish date: 2024 Jul
-
Study on the Underlying Mechanism of Yinhua Gout Granules in the Treatment of Gouty Arthritis by Integrating Transcriptomics and Network Pharmacology
Journal: Drug Design Development And Therapy
DOI:
IF: 4.7
Application: WB
Reactivity: Rat
Publish date: 2024 Jul
-
Research on the role and mechanism of Aloe vera (L.) Burm. f. in the treatment of burn: Based on network pharmacology analysis and experimental verification
Journal: Journal Of Holistic Integrative Pharmacy
DOI:
IF:
Application: WB
Reactivity: Mouse
Publish date: 2024 Dec
-
Injectable, Electroconductive, Free Radical Scavenging Silk Fibroin/Black Phosphorus/Glycyrrhizic Acid Nanocomposite Hydrogel for Enhancing Spinal Cord Repair
Journal: Advanced Healthcare Materials
DOI:
IF: 10
Application: WB
Reactivity: Mouse
Publish date: 2024 Apr
-
ESL Attenuates BLM-induced IPF in Mice: Dual Mediation of the TLR4/NF-κB and TGF-β1/PI3K/Akt/FOXO3a Pathways
Journal: Phytomedicine
DOI:
IF: 7.9
Application: WB
Reactivity: Mouse
Publish date: 2024 Apr
-
Bladder cancer intrinsic LRFN2 drives anticancer immunotherapy resistance by attenuating CD8+ T cell infiltration and functional transition.
Journal: Journal For Immunotherapy Of Cancer
DOI:
IF: 10.9
Application: WB
Reactivity: Human,Mouse
Publish date: 2023 Oct
-
Methylprednisolone Promotes Mycobacterium smegmatis Survival in Macrophages through NF-κB/DUSP1 Pathway
Journal: Microorganisms
DOI:
IF: 4.926
Application: WB
Reactivity: Mouse
Publish date: 2023 Mar
-
Lactobacillus plantarum LLY-606 supplementation ameliorates hyperuricemia via modulating intestinal homeostasis and relieving inflammation.
Journal:
DOI:
IF: 6.317
Application: WB
Reactivity: Mouse
Publish date: 2023 Jun
-
Sauchinone alleviates dextran sulfate sodium-induced ulcerative colitis via NAD(P)H dehydrogenase [quinone] 1/NF-kB pathway and gut microbiota
Journal: Frontiers In Microbiology
DOI:
IF: 6.064
Application: WB
Reactivity: Mouse
Publish date: 2023 Jan
-
Amygdalin Delays Cartilage Endplate Degeneration and Improves Intervertebral Disc Degeneration by Inhibiting NF-κB Signaling Pathway and Inflammatory Response
Journal: Journal Of Inflammation Research
DOI:
IF:
Application: WB
Reactivity: Mouse
Publish date: 2023 Aug
-
The flavonoids extract from Okra flowers protects against DSS-induced colitis via regulating NF-κB signaling pathway and gut microbiota
Journal: Journal Of Functional Foods
DOI: 10.1016/j.jff.2022.105335
IF: 5.223
Application: WB
Reactivity: Mouse
Publish date: 2022 Nov
-
Blockade of mIL‐6R alleviated lipopolysaccharide‐induced systemic inflammatory response syndrome by suppressing NF‐κB‐mediated Ccl2 expression and inflammasome activation
Journal: Medicine And Communication
DOI:
IF: NA
Application: WB
Reactivity: Human
Publish date: 2022 May
-
Galactooligosaccharides as a protective agent for intestinal barrier and its regulatory functions for intestinal microbiota
Journal: Food Research International
DOI:
IF: 6.475
Application:
Reactivity: Mouse
Publish date: 2022 May
-
TNF antagonist sensitizes synovial fibroblasts to ferroptotic cell death in collagen-induced arthritis mouse models
Journal: Nature Communications
DOI:
IF: 14.919
Application: WB
Reactivity: Mouse
Publish date: 2022 Feb
-
HSP60 regulates the cigarette smoke-induced activation of TLR4-NF-κB-MyD88 signalling pathway and NLRP3 inflammasome
Journal: International Immunopharmacology
DOI:
IF: 5.6
Application: WB
Reactivity: Mouse
Publish date: 2022 Feb
-
miR‐20a‐5p regulated SMAD6 to inhibit chondrogenesis of hDPSCs
Journal: Oral Diseases
DOI:
IF: 3.8
Application: WB
Reactivity: Human
Publish date: 2022 Aug
-
The role of alcohol dehydrogenase 1C in regulating inflammatory responses in ulcerative colitis
Journal: Biochemical Pharmacology
DOI:
IF: 5.8
Application: WB
Reactivity: Human,Mouse
Publish date: 2021 Oct
Products with the same target and pathway
Phospho-IKB alpha (S32) Recombinant Rabbit Monoclonal Antibody [ST53-05] - BSA and Azide free
Application: WB,IF-Cell,IP
Reactivity: Human,Mouse
Conjugate: unconjugated
IKB alpha Recombinant Rabbit Monoclonal Antibody [SZ00-07] - BSA and Azide free
Application: WB,IF-Cell,IF-Tissue,IHC-P,IP,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
IKB alpha Recombinant Rabbit Monoclonal Antibody [SZ00-07]
Application: WB,IF-Cell,IF-Tissue,IHC-P,IP,FC
Reactivity: Human,Mouse,Rat,Zebrafish
Conjugate: unconjugated
Phospho-IKB alpha (S32/S36) Recombinant Rabbit Monoclonal Antibody [PSH06-76] - BSA and Azide free
Application: WB,IHC-P,IF-Cell
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
Phospho-IKB alpha (S32/S36) Recombinant Rabbit Monoclonal Antibody [PSH06-76]
Application: WB,IHC-P,IF-Cell
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated